1. CTHRC1 promotes anaplastic thyroid cancer progression by upregulating the proliferation, migration, and invasion of tumor cells
   Yong Chen et al, 2023, PeerJ CrossRef
2. Repurposing cyclovirobuxine D as a novel inhibitor of colorectal cancer progression via modulating the CCT3/YAP axis
   Yiman Liu et al, 2024, British Journal of Pharmacology CrossRef
3. Cyclovirobuxine D Induces Apoptosis and Mitochondrial Damage in Glioblastoma Cells Through ROS-Mediated Mitochondrial Translocation of Cofilin
   Lin Zhang et al, 2021, Frontiers in Oncology CrossRef
4. The Role of CTHRC1 in Regulation of Multiple Signaling and Tumor Progression and Metastasis
   Dan Mei et al, 2020, Mediators of Inflammation CrossRef
5. Targeting the key players of phenotypic plasticity in cancer cells by phytochemicals
   Sajad Fakhri et al, 2024, Cancer and Metastasis Reviews CrossRef
6. Light-Responsive Micelles Loaded With Doxorubicin for Osteosarcoma Suppression
   Jiayi Chen et al, 2021, Frontiers in Pharmacology CrossRef
7. Pull the plug: Anti‐angiogenesis potential of natural products in gastrointestinal cancer therapy
   Yanling Ai et al, 2022, Phytotherapy Research CrossRef
8. Cyclovirobuxine D, a cardiovascular drug from traditional Chinese medicine, alleviates inflammatory and neuropathic pain mainly via inhibition of voltage-gated Cav3.2 channels
   Deyuan Su et al, 2022, Frontiers in Pharmacology CrossRef
9. Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review
   Sajad Fakhri et al, 2024, Cancer and Metastasis Reviews CrossRef
10. Hydroalcoholic extract of Buxus sempervirens shows antiproliferative effect on melanoma, colorectal carcinoma and prostate cancer cells by affecting the autophagic flow
    Anna Rita Volpe et al, 2023, Frontiers in Pharmacology CrossRef